Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rebecca Zisser/Axios

The U.S. is facing a series of potentially devastating health care threats — some within the next decade, and some that have already manifested as a part of everyday life. 

Between the lines: As Washington struggles with staggering hospital bills and prescription drug costs, society also faces even more difficult problems fueled by the aging population, the economics of health care and the rise of drug-resistant infections.

The big picture: The cost issues Washington is debating are important. It's just that those problems pale in comparison to the ones political leaders are not focusing on.

  • But many of these those will soon become impossible to ignore.
Affordability issues

Premiums, deductibles and the underlying cost of care will all only continue to go up.

  • As Baby Boomers age into Medicare, health care providers will likely raise their rates for private insurance to make up for the lost revenue — squeezing employers, employees and taxpayers in the process.
  • Medicare's hospital benefit is expected to be spending more than it has to spend by 2026, threatening benefits.
  • Most middle-income seniors won't be able to afford long-term care, as the NYT recently reported.
  • The drug pricing debate is stuck mostly in the past, as the future of medicine increasingly features multi-million-dollar personalized medications unlikely to ever have competition.
Access issues

A flood of rural hospital closures is leaving many communities with no easy access to emergency care.

  • The Washington Post profiled a hospital on the brink of closure this weekend, and Kaiser Health News yesterday wrote about what life is like post-hospital closure.
  • The U.S. will be short as many as 122,000 doctors by 2032, according to a recent study by the Association of American Medical Colleges. Primary care will be short between 21,100 and 55,200 doctors, while specialty care will face a shortage of between 24,800 and 65,800.
Health threats

The opioid epidemic continues to ravage the country, with no real end in sight.

Drug-resistant infections continue to rise, without any real government incentives for drug companies to develop new antibiotics. The UN warned last month that antimicrobial resistance could kill 10 million people a year globally by 2050.

Climate change will also be a health care crisis; it's expected to make infectious, tropical and respiratory diseases worse. Pharmaceutical companies are already preparing for that business opportunity.

The bottom line: It's hard to see how any of these topics become more prominent than the debate over Medicare for All or how to drive down spending on prescription drugs over the next couple of years. But we avoid dealing with them at our own peril.

Go deeper

Updated 2 mins ago - Politics & Policy

White House stands by imperiled Tanden nomination after Senate panel postpones hearing

Neera Tanden. Photo: Anna Moneymaker/The New York Times/Bloomberg via Getty Images

The Senate Homeland Security Committee is postponing a confirmation hearing scheduled Wednesday for Neera Tanden, Axios has learned, a potential death knell for President Biden's nominee to lead the Office of Management and Budget.

The latest: Asked Wednesday afternoon whether Tanden has offered to withdraw her nomination, Psaki told reporters, "That’s not the stage we’re in." She noted that it's a "numbers game" and a "matter of getting one Republican" to support the nomination.

Acting Capitol Police chief: Officers were unsure of lethal force rules on Jan. 6

Photo: Chip Somodevilla/Getty Images

Acting U.S. Capitol Police Chief Yogananda Pittman wrote in prepared remarks for a House hearing on Thursday that officers in her department were "unsure of when to use lethal force" during the Jan. 6 insurrection.

Why it matters: Capitol Police did deploy lethal force on Jan. 6 — shooting and killing 35-year-old Ashli Babbit — but have faced questions over why officers appeared to be less forceful against pro-Trump rioters than participants in previous demonstrations, including those over Black Lives Matter and now-Supreme Court Justice Brett Kavanaugh.

United CEO is confident people will feel safe traveling again by 2022

Axios' Joann Muller and United CEO Scott Kirby. Photo: Axios

United Airlines CEO Scott Kirby believes that people will feel safe traveling again by this time next year, depending on the pace of vaccinations and the government's ongoing response to the pandemic, he said at an Axios virtual event.

Why it matters: Misery for global aviation is likely to continue and hold back a broader economic recovery if nothing changes, especially with new restrictions on international border crossings. U.S. airlines carried about 60% fewer passengers in 2020 compared with 2019.